Jazz Pharmaceuticals plc <JAZZ.O>: Raymond James raises target price to $295 from $275
JAZZ•Related News
IZEA schedules Q2 2026 earnings conference call
IZEA•
Traction Uranium flags multiple radiometric anomalies in airborne survey at Aurora uranium project
URA•
Mineralys Therapeutics to report Q2 results, host conference call
MLYS•
Vertex names Chatelle Lynch chief people officer in leadership expansion
VERX•
Rani Therapeutics names Michelle Gilson to board as audit committee chair
RANI•